Verano Holdings (VRNO) Enterprise Value (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Enterprise Value of -$75.8 million for Q1 2026, up 11.85% year-over-year from -$67.8 million in Q1 2025, and up 10.29% quarter-over-quarter from -$84.5 million in Q4 2025.
Verano Holdings (VRNO) Enterprise Value (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Enterprise Value for 6 consecutive years, with -$75.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value rose 11.85% year-over-year to -$75.8 million; the TTM figure through Mar 2026 stood at -$75.8 million (up 11.85% YoY), while the FY2025 annual figure was -$84.5 million, up 5.22% from the prior year.
- Enterprise Value improved to -$75.8 million in Q1 2026 per VRNO's latest filing, from -$84.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$65.2 million in Q3 2024 and bottomed at -$193.8 million in Q1 2024.
- Historically, Enterprise Value has averaged -$102.2 million across 5 years, with a median of -$87.6 million in 2024.
- Annual changes were most pronounced in 2023 — Enterprise Value slumped 105.96% — and 2025, when it soared 55.63%.
- Verano Holdings' Enterprise Value stood at -$84.9 million in 2022, then plunged by 105.96% to -$174.8 million in 2023, then surged by 48.99% to -$89.2 million in 2024, then increased by 5.22% to -$84.5 million in 2025, then grew by 10.29% to -$75.8 million in 2026.
- Business Quant data shows VRNO's Enterprise Value at -$75.8 million in Q1 2026, -$84.5 million in Q4 2025, and -$84.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | Verano Holdings | 438.82 Mn | 353.62 Mn | 99.70 Mn | -87.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -87.01 Mn |
| Mar 31, 2026 | -75.80 Mn |
| Dec 31, 2025 | -84.50 Mn |
| Sep 30, 2025 | -84.40 Mn |
| Jun 30, 2025 | -70.35 Mn |
| Mar 31, 2025 | -86.00 Mn |
| Dec 31, 2024 | -89.15 Mn |
| Sep 30, 2024 | -65.21 Mn |
| Jun 30, 2024 | -130.05 Mn |
| Mar 31, 2024 | -193.80 Mn |
| Dec 31, 2023 | -174.76 Mn |
| Sep 30, 2023 | -129.84 Mn |
| Jun 30, 2023 | -102.58 Mn |
| Mar 31, 2023 | -95.13 Mn |
| Dec 31, 2022 | -84.85 Mn |
| Sep 30, 2022 | -76.42 Mn |
| Jun 30, 2022 | -92.83 Mn |
| Dec 31, 2021 | -97.84 Mn |